NCT05036980View on ClinicalTrials.gov

Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at Altitude

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

April 8, 2022

Study Completion Date

April 10, 2022

Conditions
Healthy Volunteers With Induced Hypoxia
Interventions
DRUG

Trans Sodium Crocetinate

Single IV bolus

Trial Locations (1)

22710

Duke University Medical Center, Durham

Sponsors
All Listed Sponsors
lead

Diffusion Pharmaceuticals Inc

INDUSTRY